Clinical Trials Browser

Phase EARLY_PHASE1 × Hodgkin Disease × Nivolumab × Clear all

NCT04134325 2025-04-16

Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Phase EARLY_PHASE1 Active not recruiting

Hodgkin Disease